市場調查報告書
商品編碼
1543638
藥品和生物技術的製造和供應交易(2019-2024)Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology 2019-2024 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
本報告深入了解和分析公司如何以及為何進行製造和供應交易。
本報告提供了2019年至2024年製造和供應交易的詳細資訊。
本報告提供了各方之間宣布的製造和供應交易的付款條件。這些資料提供了有關支付條款和其他交易條款的寶貴見解。
了解潛在合作夥伴談判條款的彈性,並深入了解談判過程,以了解條款談判期間的預期結果。許多小型企業會要求提供付款條件的詳細信息,但在包括付款方式和權利如何轉讓時,細節是關鍵。
本報告涵蓋2019年以來宣布的製造和供應交易,全面列出目前協議案件/合作夥伴資料庫中記錄的內容,並包括可用的財務條款,以及公司及其合作夥伴向證券交易委員會提交的實際許可協議文件的線上副本的連結。
本報告為讀者提供了以下主要好處:
此報告包含以下資訊:
此報告列出了可獲得資訊的交易:
透過分析合約協議,實質審查可以:
Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology provides a detailed understanding and analysis of how and why companies enter manufacturing and supply deals.
Fully revised and updated, the report provides details of manufacturing and supply deals from 2019 to 2024.
The report provides access to manufacturing and supply deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.
Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.
This report contains a comprehensive listing of manufacturing and supply deals announced since 2019 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual manufacturing and supply contract documents as submitted to the Securities Exchange Commission by companies and their partners.
The initial chapters of this report provide an orientation of manufacturing and supply dealmaking and business activities.
Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview and analysis of the trends in manufacturing and supply as well as a discussion on the merits of the type of deal.
Chapter 3 provides an overview of the structure of manufacturing and supply deals.
Chapter 4 provides a review of the leading manufacturing and supply deals since 2019. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.
Chapter 5 provides a comprehensive listing of the top 25 most active manufacturing and supply dealmaker companies. Each deal title links via Current Agreements deals and alliances database to an online version of the full deal record, and where available, the actual contract document, providing easy access to each deal record on demand.
Chapter 6 provides a comprehensive and detailed review of manufacturing and supply deals organized by company A-Z, therapy, technology and industry type signed and announced since 2016 where a contract document is available. Contract documents provide an indepth insight into the actual deal terms agreed between the parties with respect to the manufacturing and supply deal.
The deal directory includes a comprehensive listing of all manufacturing and supply deals announced since 2019. Each listing is organized as a deal directory by company A-Z, therapeutic area and technology type. Each deal title links via hyperlink to an online version of the deal record including, where available, the actual contract document.
The report also includes numerous table and figures that illustrate the trends and activities in manufacturing and supply dealmaking since 2019.
In conclusion, this report provides everything a prospective dealmaker needs to know about manufacturing and supply alliances.
Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology provides the reader with the following key benefits:
Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology includes:
In Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology, the available deals are listed by:
Analyzing contract agreements allows due diligence of: